期刊文献+

炭疽保护性抗原受体结合区的关键氨基酸位点分析

Analysis of key amino acids of the Bacillus anthracis protective antigen receptor-binding region
原文传递
导出
摘要 目的分析炭疽毒素保护性抗原(PA)受体结合区与其功能相关的关键氨基酸位点。方法通过定点突变的方法将PA的Asp683分别突变成为一系列带有不同电荷以及不同长度侧链的氨基酸,通过细胞毒性实验分别探询电荷及立体结构对其活性的影响。同时对Asp683的一些邻近氨基酸进行了定点突变的研究。结果细胞毒性实验显示,不同的突变导致了PA活性不同程度的下降,其中Asp683电荷的改变对其活性的影响尤为明显,但当它突变为不带电荷的氨基酸时,PA仍然保留了一定的活性;而当Asp683突变为带正电的Lys后,PA却保留了相对较高的活性。结论Asp683所带的负电荷在PA与其受体的相互作用中起着关键的作用,但PA与其受体之间的相互作用可能还通过一些其他方式进行。 Objective To analyze the key amino acids of the Bacillus anthracis protective antigen(PA) receptor-binding region. Methods Asp^683 was converted into a series of other amino acids by site-directed mutagenesis. Substituted PA proteins were analyzed by cellular cytotoxicity assays to study the influence of charge or dimensional structure of the acid. Furthermore, some variants with neighbor amino acids of Asp^683 were constructed and analyzed by the same way. Results Results of the cellular cytotoxicity assays showed that different mutations gave rise to different extents of decrease in its toxicity. The influence of the change of related negative charge of Asp^683 was especially evident while Asp^683 was converted into electropositive Lys, it still kept some toxicity. Conclusion The negative charge of Asp^683 plays a very crucial role in the interaction between PA and its receptor, though other mechanisms are potentially present.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2005年第11期865-868,共4页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金资助项目(30300016)
关键词 炭疽保护性抗原 受体结合区 定点突变 细胞毒性实验 Bacillus anthracis protective antigen Receptor-binding region Site-directed mutagenesis Cellular cytotoxicity assay
  • 相关文献

参考文献28

  • 1Green BD, Battisti L, Koehler TM, et al. Demonstration of a capsule plasmid in Bacillus anthracis. Infect Immun, 1985, 49: 291-297.
  • 2Mikesell P, Ivins BE, Ristroph JD, et al. Evidence for plasmid-mediated toxin production in Bacillus anthracis. Infect Immun, 1983, 39: 371-376.
  • 3Chaudry GJ, Moayer M, Liu S, et al. Quickening the pace of anthrax research: three advances point towards possible therapies. Trends Microbiol, 2002, 10(2): 58-62.
  • 4Stanley JL, Smith H. Purification of factor I and recognition of a third factor of the anthrax toxin. J Gen Microbiol, 1961, 26: 49-66.
  • 5Beall FA, Taylor MJ, Thorne CB. Rapid lethal effect in rats of a third factor of the anthrax toxin. J Bacteriol, 1962, 83: 1274-1280.
  • 6Ascenzi P, Visca P, Ippplito G, et al. Anthrax toxin: a tripartite lethal combination. FEBS Letters, 2002, 531: 384-388.
  • 7Bradley K, Mogridge J, Mourez J, et al. Identication of the cellular receptor for anthrax toxin. Nature, 2001, 414: 225-229.
  • 8Miline J, Furlong D, Hanna P, et al. Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J Biol Chem, 1994, 269: 29039-29046.
  • 9Miline J, Collier R. PH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen. Mol Microbiol, 1993, 10: 647-653.
  • 10Elliott J, Mogridge J, Collier R. A quantitative study of the interactions of Bacillus anthracis edema factor and lethal factor with activated protective antigen. Biochemistry, 2000, 39: 6706-6713.

二级参考文献17

  • 1[1]Swanson-Biearman B,Krenzelok EP.Delayed life-threatening reaction to anthrax vaccine.J Toxicol Ciln Toxicol,2001,39(1):81-84
  • 2[2]Demicheli V,Rivetti D,Deeks JJ et al.The effectiveness and safety of vaccines against human anthrax:a systematic review.Vaccine,1998,16(9-10):880-884
  • 3[3]Baillie L.The development of new vaccines against Bacillus anthracis.J Appl Microbiol,2001,91:609-613
  • 4[4]Leppla SH.Development of an improved vaccine for anthrax.J Clin Invest,2002,110(2):141-144
  • 5[5]Enserink M,Marshall Eliot.New anthrax vaccine gets a green light.Science,2002,296:639-640
  • 6[6]Singh Y,Leppla SH,Bhatnagar R et al.Internalization and processing of lethal toxin by toxin-sensitive and-resistant cells.J Biol Chem,1989,264(19):11099-11102
  • 7[7]Kobiler D,Gozes Y,Rosenberg H et al.Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization.Infect Immun,2002,70(2):544-550
  • 8[8]Ivins BE,Pitt ML,Fellows PF et al.Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques.Vaccine,1998,16:1141-1148
  • 9[9]Singh Y,Ivins BE,Leppla SH et al.Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis.Infect Immun,1998,66:3447-3448
  • 10Duesbery N S, Vande Woude G F. Anthrax toxins. Cell Mol Life Sci, 1999,55(12):1599-1609.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部